Search Results - "Buchsbaum, JC"

Operational Ontology for Oncology (O3) – A Professional Society Based, Multi-Stakeholder, Consensus Driven Informatics Standard Supporting Clinical and Research use of “Real -World” Data from Patients Treated for Cancer: Operational Ontology for Radiation Oncology by Mayo, CS, Feng, MU, Brock, KK, Kudner, R, Balter, P, Buchsbaum, JC, Caissie, A, Covington, E, Daugherty, EC, Dekker, AL, Fuller, CD, Hallstrom, AL, Hong, DS, Hong, JC, Kamran, SC, Katsoulakis, E, Kildea, J, Krauze, AV, Kruse, JJ, McNutt, T, Mierzwa, M, Moreno, A, Palta, JR, Popple, R, Purdie, TG, Richardson, S, Sharp, GC, Shiraishi, S, Tarbox, L, Venkatesan, AM, Witztum, A, Woods, KE, Yao, J, Farahani, K, Aneja, S, Gabriel, PE, Hadjiiski, L, Ruan, D, Siewerdsen, JH, Bratt, S, Casagni, M, Chen, S, Christodouleas, J, DiDonato, A, Hayman, J, Kapoor, R, Kravitz, S, Sebastian, S, Von Siebenthal, M, Xiao, Y

Get full text

Survival by Radiation therapy oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: A retrospective study by BUCHSBAUM, Jeffrey C, SUH, John H, LEE, Shih-Yuan, CHIDEL, Mark A, GRESKOVICH, John F, BARNETT, Gene H

“…In a population of patients with brain metastases from melanoma, the authors sought to determine whether various therapies provided any benefit at all, whether…”
Get full text

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era by Kupelian, Patrick A, Buchsbaum, Jeffrey C, Patel, Chandrika, Elshaikh, Mohamed, Reddy, Chandana A, Zippe, Craig, Klein, Eric A

“…To study the impact of biochemical failure on overall survival rates during the first 10 years after definitive radiotherapy for localized prostate cancer. The…”
Get more information

Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome by Kupelian, Patrick A, Buchsbaum, Jeffrey C, Elshaikh, Mohamed A, Reddy, Chandana A, Klein, Eric A

“…In patients treated with radical prostatectomy in the prostate-specific antigen (PSA) era, it has been demonstrated that the year of treatment in the PSA era…”
Get more information

Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10) by Kupelian, P A, Buchsbaum, J C, Reddy, C A, Klein, E A

“…To study the radiation dose response as determined by biochemical relapse-free survival in patients with favorable localized prostate cancers, i.e., Stage…”
Get more information

Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above by Kupelian, Patrick A., Buchsbaum, Jeffrey C., Elshaikh, Mohamed, Reddy, Chandana A., Zippe, Craig, Klein, Eric A.

“…BACKGROUND To review the biochemical recurrence‐free survival (bRFS) rates of treatment with either external beam radiotherapy or radical prostatectomy in…”
Get full text

Matrix-Assisted Laser Desorption/Ionization of Noncovalently Bound Compounds by Woods, A. S, Buchsbaum, J. C, Worrall, T. A, Berg, J. M, Cotter, R. J

“…Matrix-assisted laser desorption/ionization mass spectrometry was used to obtain spectra of peptide-metal ion complexes formed by a zinc finger peptide of the…”
Get full text

Kinetics of metal binding by a zinc finger peptide by Buchsbaum, Jeffrey C, Berg, Jeremy M

“…The kinetics of cobalt(II) and zinc(II) binding by a prototypical zinc finger peptide has been examined by stopped-flow spectrometry. Cobalt(II) binding was…”
Get full text